Clinical Trial: Prostatic Hyperplasia Treatment and Cancer Prevention
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Treatment of Prostatic Hyperplasia With Topical Papaverine
Brief Summary: Treatment of patients with prostatic hyperplasia with topical papaverine.
Detailed Summary: Patients with obstructive voiding and high PSA to be studied for the regression of symptoms and declining PSA.
Sponsor: Manchanda Medical Clinic
Current Primary Outcome: Laboratory tests to measure regression of symptoms [ Time Frame: every 4 weeks up to 16 weeks ]
Original Primary Outcome: Laboratory tests to measure regression of symptoms [ Time Frame: every 4 weeks up to 16 weeks ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Manchanda Medical Clinic
Dates:
Date Received: December 12, 2016
Date Started: April 20, 2017
Date Completion: June 30, 2017
Last Updated: March 21, 2017
Last Verified: March 2017